← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 15, 2017Last known activity
Oct 13, 2020
Acquired by Adicet Bio on Apr 29, 2020
Timeline
2010s
- Jan 1, 2016
resTORbio, Inc.— Founded
2020s
- Apr 29, 2020
Adicet Bio— Acquired By
Drugs by trial phase (3 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT04584710Study directorPhase 2Oct 13, 2020
- NCT04584710Lead sponsorPhase 2Oct 13, 2020
- NCT04409327Lead sponsorPhase 3May 31, 2020
- NCT04409327Study directorPhase 3May 31, 2020
- NCT04139915Lead sponsorPhase 3Oct 21, 2019
- NCT04139915Study directorPhase 3Oct 21, 2019
- NCT04668352Lead sponsorPhase 3Apr 15, 2019
- NCT03373903Lead sponsorPhase 2Nov 15, 2017
- NCT03373903Study directorPhase 2Nov 15, 2017
Details
- Founded
- Boston, MA, US Jan 1, 2016
- Last known activity
- Oct 13, 2020